Melanotan 2 Effects: What Users Report and What the Research Cautions
Before the details
This page is the honest, plain account of what Melanotan 2 does to people — the good and the bad — and who has reason to be careful. It comes in two layers, kept deliberately separate. The first layer is what users themselves describe: a fast tan, less appetite, a surge in sex drive, and a long list of unpleasant effects from nausea to darkening moles. That layer is anecdotal — community reports, not proof.
The second layer is what doctors have documented and published: cases of new and changing moles, melanoma, kidney injury, prolonged painful erections, and more. Those are cited. We never give a dose and never tell you what to do. Read the first layer as 'what people say' and the second as 'what the literature records,' and keep the two apart in your head the way we keep them apart on the page.
What people report
These are effects described by the research-use community — anecdotal, not clinical evidence, and not verified by controlled trials. No doses are given.
The reported benefits cluster tightly around appearance. The one people seek most is a rapid, deep tan with little or no sun: skin darkening noticeably within days, and a deeper color reached with far less sunbed or sunlight time than usual. Many describe cosmetic satisfaction and confidence as the reason they keep using it despite side effects, and some discussions note this can shade into preoccupation with appearance. Reduced appetite and weight loss is very commonly reported, often from the first dose; people split on whether this is a bonus or unwanted. Increased libido and spontaneous erections are commonly reported by men, often starting with the first or second dose — welcomed by some, found uncomfortable or embarrassing by others; women also report heightened arousal. A minority treat their darker, longer-lasting color as protection against burning, though this is a user belief, not demonstrated protection, and many still report burning.
The adverse reports are longer, and several bear directly on this site's focus. Nausea, sometimes with vomiting, is one of the most consistently described effects, typically in the first hour after a dose and worst in the early days. Facial flushing and a hot feeling comes on within minutes to an hour. A distinctive urge to stretch and yawn repeatedly is frequently mentioned soon after dosing. Many describe the tan arriving uneven, blotchy, or unnaturally long-lasting, sometimes with an orange or grey cast, and fading slowly and patchily over weeks to months after stopping. A run-down, flu-like fatigue in the first days is common enough that users named it 'melanotan flu.' Because it is injected, injection-site reactions — redness, itching, bruising, small lumps — are commonly reported.
Three adverse reports matter most here. Users very commonly notice existing moles and freckles darkening, often before the overall tan develops, with spots standing out sharply. A recurring and frankly alarming report among longer-term users is the appearance of brand-new moles, sometimes many at once and sometimes within a day or two of a dose — often the very thing that sends a person to a doctor. And users describe selective darkening of the lips, gums, old scars, and genital and underarm skin, which can look conspicuous and out of place. These community reports line up with the published case literature below — but the reports themselves remain anecdotal.
Melanotan 2 reviews and Reddit reports, in context
Search demand exists for Melanotan 2 reviews and for melanotan 2 reddit threads, and the picture above is essentially a structured summary of what those informal sources describe. A published qualitative study of online discussion forums catalogued exactly this mix — the prized tan alongside nausea, flushing, mood changes, and worry about moles — and treated the forums as a window onto unsupervised use rather than as evidence of safety [22]. A separate analysis of how the compound is marketed and perceived on social media (the so-called 'Barbie drug') found a persistent gap between the promotional framing and the documented risks [23]. Read user reviews as lived experience worth listening to, and read the cited literature below for what has actually been measured.
Safety and cautions
New, changing, or darkening moles, and melanoma risk. As a non-selective melanocortin agonist acting on MC1R, Melanotan 2 drives melanocyte activity throughout the skin. Case reports describe eruptive new nevi, dysplastic (atypical) nevi, and darkening or change in existing moles after use [4][5][6][13]. Several reports further document melanoma and melanoma in situ arising in users [7][8][9], and dermoscopy studies show measurable changes in pigmented lesions during use [10]. A teenage patient with an inherited high-mole-and-melanoma syndrome developed a dysplastic nevus after combining the compound with sunbed use [11]. The long-term melanoma risk is not established, but it is a serious theoretical and case-reported concern — and any new or changing mole during or after use is a reason to see a dermatologist promptly.
Rhabdomyolysis and acute kidney injury. A published case links a Melanotan 2 injection to systemic toxicity with rhabdomyolysis — severe muscle breakdown that releases muscle contents into the blood [14] — and a separate case with literature review describes renal infarction (loss of blood supply to part of a kidney) attributed to its use [15]. These point to potential serious muscle and kidney injury whose mechanisms are not fully understood and may relate to the peptide's effects on blood vessels.
Priapism — a prolonged, painful erection. Because melanocortin signaling promotes erections, several reports describe priapism following tanning injections, including after apparent overdose [16][17][18]. Priapism is a urological emergency that can permanently damage erectile tissue if not treated quickly.
Posterior reversible encephalopathy syndrome (PRES). A case report describes PRES — a reversible condition involving brain swelling that can present with headache, seizures, visual disturbance, and high blood pressure — in association with melanotan use [19], consistent with the compound's reported effects on blood pressure.
Blood-pressure and cardiovascular effects, plus the nausea. Preclinical work on the hemodynamic actions of alpha-MSH analogs shows melanocortin agonists can raise blood pressure [20], and animal studies show this pressor effect worsens when nitric oxide signaling is impaired [21]. Together with the very commonly reported nausea — which was severe in roughly 13% of subjects at the 0.025 mg/kg study dose [25] — this points to meaningful cardiovascular and gastrointestinal effects that are poorly characterized in humans using unregulated product.
Unregulated product: unknown contents. Analytical studies of melanotan products bought online repeatedly find inaccurate labeling, variable or unverifiable peptide content, and impurities [12][24], and the compound appears in surveys of falsified and black-market injectables [26]. With no quality control, a buyer cannot know the actual identity, dose, purity, or sterility of what is in the vial — which compounds every other risk above.
No approval and unknown long-term safety. Melanotan 2 has never been approved by any regulator for any use, and its development never completed late-phase trials, so its long-term human safety is simply unknown. Regulators and dermatology bodies have specifically warned against melanotan tanning products [27][28], and review articles catalogue the harms of unregulated alpha-MSH analog use [29]. It should be regarded strictly as an unapproved research chemical.
Not the approved, distinct melanocortin drugs. Melanotan 2 is sometimes confused with afamelanotide, an approved melanocortin therapy for the rare condition erythropoietic protoporphyria [30][31], and with the separately approved sexual-function melanocortin agonist developed from this peptide family [3]. Those approvals and their trial-based safety data do not extend to Melanotan 2, a different and unapproved compound.
Then and now: how the compound came to be
Melanotan 2 was designed in the late 1980s at the University of Arizona as a superpotent cyclic copy of the natural pigment hormone alpha-MSH, with the original aim of promoting a protective tan and so potentially reducing skin-cancer risk [32]. Early human work showed it could darken skin [1]; researchers then noticed the erections, which led to the small erectile-dysfunction study and to the spin-off agonist bremelanotide [2][3]. The original tanning program never reached the market. From the mid-2000s an illicit trade emerged, with the peptide sold online as unlicensed 'sun-tan jabs' and 'Barbie drug' injections despite repeated warnings from regulators and dermatologists [33][27]. It remains an unapproved research chemical with no sanctioned medical or cosmetic use [32].